Efficacy of in‐class interleukin‐23 inhibitor switching: risankizumab following guselkumab failure in moderate‐to‐severe psoriasis treatment
Gespeichert in:
| Veröffentlicht in: | British journal of dermatology (1951) 2021-03, Vol.184 (3), p.559-561 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 561 |
|---|---|
| container_issue | 3 |
| container_start_page | 559 |
| container_title | British journal of dermatology (1951) |
| container_volume | 184 |
| creator | Reddy, R. Pannu, S. Fiumara, K. Kahn, J. Rosmarin, D. |
| description | |
| doi_str_mv | 10.1111/bjd.19575 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2447841691</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2497114000</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3535-bbaa46f728fcdd5f49f92a35c1db2ec1e56fcddd778e5c2c2371293b22db2bdb3</originalsourceid><addsrcrecordid>eNp1kc9OFTEYxRsigSuy4AXMJG50MdA_05mpO0VQDIkbWU_azlfovZ3pte14c13xCCx8Qp-EwoALE7tom3N-30nTg9ARwcckrxO17I-J4A3fQQvCal5SwtgLtMAYNyUWNdtHL2NcYkwY5ngP7TMqREtavkC_z4yxWupt4U1hxz-3d9rJGPM1QXAwrR41yrJwY5VNPhRxY5O-seP1-yLYKMeV_TUNUhXGO-c3WS-upwhuNYvSuilAHi8G30OQCXJe8nmL8BOys44-WBltLFIAmQYY0yu0a6SLcPh0HqCr87Pvp1_Ky2-fL04_XJaaccZLpaSsatPQ1ui-56YSRlDJuCa9oqAJ8PrB6JumBa6ppqwhVDBFafZVr9gBejvnroP_MUFM3WCjBufkCH6KHa2qpq1ILUhG3_yDLv0Uxvy6TImGkCp_dqbezZQOPsYAplsHO8iw7QjuHqrqclXdY1WZff2UOKkB-r_kczcZOJmBjXWw_X9S9_HrpznyHkK1pY0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2497114000</pqid></control><display><type>article</type><title>Efficacy of in‐class interleukin‐23 inhibitor switching: risankizumab following guselkumab failure in moderate‐to‐severe psoriasis treatment</title><source>Wiley Online Library Journals Frontfile Complete</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Reddy, R. ; Pannu, S. ; Fiumara, K. ; Kahn, J. ; Rosmarin, D.</creator><creatorcontrib>Reddy, R. ; Pannu, S. ; Fiumara, K. ; Kahn, J. ; Rosmarin, D.</creatorcontrib><identifier>ISSN: 0007-0963</identifier><identifier>EISSN: 1365-2133</identifier><identifier>DOI: 10.1111/bjd.19575</identifier><identifier>PMID: 32998185</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Monoclonal antibodies ; Psoriasis</subject><ispartof>British journal of dermatology (1951), 2021-03, Vol.184 (3), p.559-561</ispartof><rights>2020 British Association of Dermatologists</rights><rights>Copyright © 2021 British Association of Dermatologists</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3535-bbaa46f728fcdd5f49f92a35c1db2ec1e56fcddd778e5c2c2371293b22db2bdb3</citedby><cites>FETCH-LOGICAL-c3535-bbaa46f728fcdd5f49f92a35c1db2ec1e56fcddd778e5c2c2371293b22db2bdb3</cites><orcidid>0000-0003-2786-0708</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fbjd.19575$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fbjd.19575$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32998185$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Reddy, R.</creatorcontrib><creatorcontrib>Pannu, S.</creatorcontrib><creatorcontrib>Fiumara, K.</creatorcontrib><creatorcontrib>Kahn, J.</creatorcontrib><creatorcontrib>Rosmarin, D.</creatorcontrib><title>Efficacy of in‐class interleukin‐23 inhibitor switching: risankizumab following guselkumab failure in moderate‐to‐severe psoriasis treatment</title><title>British journal of dermatology (1951)</title><addtitle>Br J Dermatol</addtitle><subject>Monoclonal antibodies</subject><subject>Psoriasis</subject><issn>0007-0963</issn><issn>1365-2133</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp1kc9OFTEYxRsigSuy4AXMJG50MdA_05mpO0VQDIkbWU_azlfovZ3pte14c13xCCx8Qp-EwoALE7tom3N-30nTg9ARwcckrxO17I-J4A3fQQvCal5SwtgLtMAYNyUWNdtHL2NcYkwY5ngP7TMqREtavkC_z4yxWupt4U1hxz-3d9rJGPM1QXAwrR41yrJwY5VNPhRxY5O-seP1-yLYKMeV_TUNUhXGO-c3WS-upwhuNYvSuilAHi8G30OQCXJe8nmL8BOys44-WBltLFIAmQYY0yu0a6SLcPh0HqCr87Pvp1_Ky2-fL04_XJaaccZLpaSsatPQ1ui-56YSRlDJuCa9oqAJ8PrB6JumBa6ppqwhVDBFafZVr9gBejvnroP_MUFM3WCjBufkCH6KHa2qpq1ILUhG3_yDLv0Uxvy6TImGkCp_dqbezZQOPsYAplsHO8iw7QjuHqrqclXdY1WZff2UOKkB-r_kczcZOJmBjXWw_X9S9_HrpznyHkK1pY0</recordid><startdate>202103</startdate><enddate>202103</enddate><creator>Reddy, R.</creator><creator>Pannu, S.</creator><creator>Fiumara, K.</creator><creator>Kahn, J.</creator><creator>Rosmarin, D.</creator><general>Oxford University Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-2786-0708</orcidid></search><sort><creationdate>202103</creationdate><title>Efficacy of in‐class interleukin‐23 inhibitor switching: risankizumab following guselkumab failure in moderate‐to‐severe psoriasis treatment</title><author>Reddy, R. ; Pannu, S. ; Fiumara, K. ; Kahn, J. ; Rosmarin, D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3535-bbaa46f728fcdd5f49f92a35c1db2ec1e56fcddd778e5c2c2371293b22db2bdb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Monoclonal antibodies</topic><topic>Psoriasis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Reddy, R.</creatorcontrib><creatorcontrib>Pannu, S.</creatorcontrib><creatorcontrib>Fiumara, K.</creatorcontrib><creatorcontrib>Kahn, J.</creatorcontrib><creatorcontrib>Rosmarin, D.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of dermatology (1951)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Reddy, R.</au><au>Pannu, S.</au><au>Fiumara, K.</au><au>Kahn, J.</au><au>Rosmarin, D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy of in‐class interleukin‐23 inhibitor switching: risankizumab following guselkumab failure in moderate‐to‐severe psoriasis treatment</atitle><jtitle>British journal of dermatology (1951)</jtitle><addtitle>Br J Dermatol</addtitle><date>2021-03</date><risdate>2021</risdate><volume>184</volume><issue>3</issue><spage>559</spage><epage>561</epage><pages>559-561</pages><issn>0007-0963</issn><eissn>1365-2133</eissn><cop>England</cop><pub>Oxford University Press</pub><pmid>32998185</pmid><doi>10.1111/bjd.19575</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0003-2786-0708</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0007-0963 |
| ispartof | British journal of dermatology (1951), 2021-03, Vol.184 (3), p.559-561 |
| issn | 0007-0963 1365-2133 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2447841691 |
| source | Wiley Online Library Journals Frontfile Complete; Oxford University Press Journals All Titles (1996-Current) |
| subjects | Monoclonal antibodies Psoriasis |
| title | Efficacy of in‐class interleukin‐23 inhibitor switching: risankizumab following guselkumab failure in moderate‐to‐severe psoriasis treatment |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T10%3A59%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20of%20in%E2%80%90class%20interleukin%E2%80%9023%20inhibitor%20switching:%20risankizumab%20following%20guselkumab%20failure%20in%20moderate%E2%80%90to%E2%80%90severe%20psoriasis%20treatment&rft.jtitle=British%20journal%20of%20dermatology%20(1951)&rft.au=Reddy,%20R.&rft.date=2021-03&rft.volume=184&rft.issue=3&rft.spage=559&rft.epage=561&rft.pages=559-561&rft.issn=0007-0963&rft.eissn=1365-2133&rft_id=info:doi/10.1111/bjd.19575&rft_dat=%3Cproquest_cross%3E2497114000%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2497114000&rft_id=info:pmid/32998185&rfr_iscdi=true |